Clinical Research Directory

Inclusion Criteria: HBV Cohort - * ≥18 years old * serum HBsAg positive for \>6 months * Treatment naïve or, * Patients who had been previously treated for HBV but discontinued for at least 1 year before enrollment HCV Cohort - * ≥18 years old * HCV-Ab positive * HCV RNA positive * Treatment naïve or, * Patients who had been previously treated for HCV with a regimen containing interferon and not had a sustained virologic response. Exclusion Criteria: * HBV/HCV Co-infection * HIV * History of hepatic decompensation or hepatocellular carcinoma * Other carcinoma * Other severe liver disease * Severe Comorbidity like cardiovascular disease, diabetes etc. * Patients who had discontinued previous HCV treatment because of an adverse event. * Patients who had previously received any nucleotide analogue HCV NS5B inhibitor or any NS5A inhibitor * Patients who had discontinued previous HBV treatment because of an adverse event.